San Francisco's Sinovas Starts $75 Million China VC Fund
Published: Jun 22, 2017
Sanovas, a Bay-Area medical device maker, will start a venture capital fund in Suzhou's BioBay park, which will invest "upwards" of $75 million in Suzhou technologies. Sanovas makes innovative micro-invasive devices, and its fund will seek investments in procedures that treat unmet medical conditions at affordable prices. The company will establish an Innovation Center in the Suzhou Institute of Nanotechnology and NanoBionics (SINANO). Sanovas' Suzhou center will also serve as a sales/learning base for China.